Press – HISS

Presshiss2023-08-03T12:11:36+03:00

Microbiome Playlist

What is microbiome?

Professor Evangelos Giamarellos-Bourboulis explains what is Microbiome.

Watch on Youtube

Microbiome and antibiotics

Are antibiotics useful? Professor Evangelos Giamarellos-Bourboulis explains their impact on Microbiome.

Watch on Youtube

Antibiotic resistance

What is antibiotic resistance? Professor Evangelos Giamarellos-Bourboulis explains how this affects us.

Watch on Youtube

Limit antibiotics side effects

How can we limit side effects of antibiotics on microbiome?
Check out PROGRESS

Watch on Youtube

Recent Posts

14March, 2024

Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trial

hiss2024-03-14T14:03:07+03:00March 14th, 2024|

7February, 2024

qSOFA combined with suPAR for early risk detection and guidance of antibiotic treatment in the emergency department: a randomized controlled trial

hiss2024-02-07T15:45:40+03:00February 7th, 2024|

2February, 2024

Developing a Tool for Differentiation Between Bacterial and Viral Respiratory Infections Using Myxovirus Resistance Protein A and C-Reactive Protein

hiss2024-02-02T13:03:15+03:00February 2nd, 2024|

5January, 2024

Association of Vitamin D with Severity and Outcome of COVID-19: Clinical and Experimental Evidence

hiss2024-01-05T14:33:18+03:00January 5th, 2024|

4January, 2024

Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial

hiss2024-04-01T11:51:43+03:00January 4th, 2024|

28October, 2023

Impact of Single Nucleotide Polymorphisms of the Promoter of the TNF Gene on Adalimumab Treatment Responses in Hidradenitis Suppurativa

hiss2023-10-28T20:24:17+03:00October 28th, 2023|

12September, 2023

A randomized clinical trial of bermekimab treatment for clinical improvement of systemic sclerosis

hiss2023-10-08T16:00:21+03:00September 12th, 2023|

7September, 2023

Immune responses of patients on maintenance hemodialysis after infection by SARS-CoV-2: a prospective observational cohort study

hiss2023-09-07T17:24:36+03:00September 7th, 2023|

Presentations & Interviews

33rd European Congress of Clinical Microbiology & Infectious Diseases

A personalized immunotherapeutic approach to the treatment of sepsis: Evangelos Giamarellos, ECCMID 2023

The symposia ‘Sepsis – Biomarker-driven immunotherapy: it works.‘ (Symposia number: SY137) was presented at ECCMID 2023, 15-18 April, 2023, Copenhagen, Denmark.

Click here to watch the interview

6th Annual Meeting of the European Sepsis Alliance

Watch on Youtube

Interview with Prof. Evangelos Giamarellos-Bourboulis for the Phase 3 SAVE-MORE Study

Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.

Interview with the Evangelos Giamarellos-Bourboulis for the Phase 3 SAVE-MORE Study
Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.

Watch the interview

Press conference of the results of the SAVE-MORE trial

“Press conference of the results of SAVE-MORE trial” ERT Interview, September 2021

Watch the interview

We use necessary cookies to make our website work properly and to store your choices in relation to optional cookies.
I want to be informed about the Cookies Policy
OK